After six months of treatment, medicines called 'biologics' seem to work best to clear raised patches of psoriasis on the skin. Longer studies are needed to assess the benefits and potential unwanted ...

What are the benefits and risks of natalizumab (NTZ) in people with multiple sclerosis (MS)?

There is limited evidence to support the use of tumor necrosis factor-alpha antagonists (anti-TNF) therapy for induction of remission in children with Crohn's disease. • More well-designed studies are ...

Improvement in IIM activity, as measured by the International Myositis Assessment and Clinical Studies Group (IMACS) definitions of improvement (DOI), may be more likely with abatacept treatment ...

Due to a lack of robust evidence, we could not determine the benefits and unwanted effects of hospital networks (organised trauma systems) or individual hospitals (designated trauma centres) that are ...

Topical silver treatments and silver dressings are increasingly used for the local treatment of contaminated or infected wounds, however, there is a lack of clarity regarding the evidence for their ...

Five trials compared interventions for maintaining soft tissue health around implants and a further six trials compared interventions to recover soft tissue health where there was evidence of ...

۷۵٪ از دستورالعمل‌های جدید سازمان جهانی بهداشت در ۵ سال گذشته حداقل به 1 مرور کاکرین استناد کرده‌اند. درباره تأثیر ما بخوانید ...

Cochrane is piloting two living evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas ...

75 % der Leitlinien der Weltgesundheitsorganisation, die in den letzten 5 Jahren neu erstellt wurden, zitieren mindestens ...

Cochrane is piloting two living evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas ...

Cochrane is piloting two living evidence gap maps in 2025 to map primary research and systematic reviews in two urgent areas ...